Jones and Somaiah Review the Rationale and Design of the Peak Trial in GIST

0 Görünümler· 09/18/23
OncLive® On Air
OncLive® On Air
0 Aboneler
0
İçinde

Drs Jones and Somaiah discuss unmet needs in GIST that the Peak trial seeks to answer; the advantages of the methods and design of this trial; and how the tolerable safety profile of bezuclastinib plus sunitinib supports further research with this combination.

Daha fazla göster

 0 Yorumlar sort   Göre sırala


Bir sonraki